FOSUN PHARMA
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

FOSUN PHARMA Trademark

Serial Number: 79407348 • Registration: 7971544

FOSUN PHARMA is a trademark filed by Shanghai Fosun Pharmaceutical (Group) Co., Ltd. on July 5, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

9th Floor, No.510, Caoyang Rd.,

Entity Type: 03

Trademark Details

Filing Date

July 5, 2024

Registration Date

October 7, 2025

Published for Opposition

August 19, 2025

Goods & Services

Retail store or wholesale store services for medical supplies; retail store or wholesale store services for medicines; retail store or wholesale store services for pharmaceutical preparations; marketing services; sales promotion for others

Antiseptics; chemico-pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; anaesthetics; pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; vaccines; anti-inflammatory preparations; pharmaceuticals for the treatment of infectious diseases; pharmaceutical preparations to be inhaled for the prevention and treatment of respiratory diseases and disorders; pharmaceuticals for the treatment of cancer; balsamic preparations for medical purposes; drugs for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; biological preparations for medical purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; medicines for human purposes being pharmaceutical preparations for the treatment of infectious-related diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases and pain, metabolic diseases, anti-viral diseases, oncologic diseases; diagnostic reagents for medical purposes; pharmaceuticals for the treatment of viral diseases; diagnostic preparations for medical purposes

Medical apparatus and instruments for use in treating all treatable diseases, illnesses, and medical conditions for humans

Pharmaceutical drug development; pharmaceutical research; conducting clinical trials for others

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 30, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 12, 2026 FICS
FINAL DISPOSITION PROCESSED
Apr 12, 2026 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 9, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 23, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 23, 2026 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 7, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 7, 2025 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 3, 2025 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 19, 2025 NPUB
PUBLISHED FOR OPPOSITION
Aug 19, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 13, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 15, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 15, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 15, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 15, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 15, 2025 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 7, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 7, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 7, 2025 TROA
REFUSAL PROCESSED BY IB
Apr 19, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 3, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 3, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 28, 2025 RFCR
NON-FINAL ACTION WRITTEN
Feb 27, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 25, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 24, 2024 REPR